Masaaki Kageyama

Dr. Masaaki Kageyama


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MKMasaaki Kageyama
Masaaki Kageyama
TOTakashi Ota
Takashi Ota
MSMasaaki Sasaoka
Masaaki Sasaoka
OKOsamu Katsuta
Osamu Katsuta
KSKatsuhiko Shinomiya
Katsuhiko Shinomiya
Chemical proteasome inhibition has been a valuable animal model of neurodegeneration to uncover roles for the ubiquitin-proteasome system in the central nervous system. However, little is known about the effects of chemical proteasome inhibitors on retinal integrity. Therefore, we characterized the effects of structurally different chemical proteasome inhibitors on the retinal morphology and the mechanisms of their action in the normal adult rat eyes. Intravitreal injection of MG-262 and other proteasome inhibitors led to inner retinal degeneration. MG-262-induced inner retinal degeneration was accompanied by reduced proteasome activity, increased poly-ubiquitinated protein levels, and increased positive immunostaining of ubiquitin, 20S proteasome subunit and GADD153/CHOP in the retina. Its retinal degenerative effect was also associated with reduced retinal neurofilament light chain gene expression, reflecting retinal ganglion cell death. MG-262-induced neurofilament light chain downregulation was largely resistant to pharmacological modulation including endoplasmic reticulum stress, apoptosis or MAP kinase inhibitors. Thus, this study provides further evidence of roles for the ubiquitin-proteasome system in the maintenance of the retinal structural integrity. Chemical proteasome inhibition may be used as a novel animal model of inner retinal degeneration, including retinal ganglion cell loss, which warrants further analysis of the molecular mechanisms underlying its retinal degenerative effect.

15 April 1997 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
MKMasaaki Kageyama
Masaaki Kageyama
HFHiromi Fujita
Hiromi Fujita
KNKatsuhiko Nakata
Katsuhiko Nakata
ESEiichi Shirasawa
Eiichi Shirasawa

Verified
Journal Article
Open access
PDF file
MGMerry Gunawan
Merry Gunawan
CLChoonbing Low
Choonbing Low
KNKurt Neo
Kurt Neo
SYSiawey Yeo
Siawey Yeo
CHCandice Ho
Candice Ho
MKMasaaki Kageyama
Masaaki Kageyama
We recently demonstrated that chemical proteasome inhibition induced inner retinal degeneration, supporting the pivotal roles of the ubiquitin–proteasome system in retinal structural integrity maintenance. In this study, using beclin1-heterozygous (Becn1-Het) mice with autophagic dysfunction, we tested our hypothesis that autophagy could be a compensatory retinal protective mechanism for proteasomal impairment. Despite the reduced number of autophagosome, the ocular tissue morphology and intraocular pressure were normal. Surprisingly, Becn1-Het mice experienced the same extent of retinal degeneration as was observed in wild-type mice, following an intravitreal injection of a chemical proteasome inhibitor. Similarly, these mice equally responded to other chemical insults, including endoplasmic reticulum stress inducer, N-methyl-D-aspartate, and lipopolysaccharide. Interestingly, in cultured neuroblastoma cells, we found that the mammalian target of rapamycin-independent autophagy activators, lithium chloride and rilmenidine, rescued these cells against proteasome inhibition-induced death. These results suggest that Becn1-mediated autophagy is not an effective intrinsic protective mechanism for retinal damage induced by insults, including impaired proteasomal activity; furthermore, autophagic activation beyond normal levels is required to alleviate the cytotoxic effect of proteasomal inhibition. Further studies are underway to delineate the precise roles of different forms of autophagy, and investigate the effects of their activation in rescuing retinal neurons under various pathological conditions.

2 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMasaaki Kageyama
Masaaki Kageyama
KOKoji Ohashi
Koji Ohashi
TOTakashi Ota
Takashi Ota
Despite much effort, the molecular mechanisms of retinal ganglion cell (RGC) death remain unclear. To identify common cell death-promoting machinery in the mechanically and chemically injured retina, we profiled temporal gene expression patterns and studied their functional roles in the rodent retina. In response to axotomy and intravitreal NMDA injection, 868 genes were commonly differentially expressed compared with those in normal retinas. K-means clustering assigned those common genes to 5 clusters on the basis of their temporal expression patterns, i.e., early, intermediate and late upregulated gene clusters, and early and late downregulated clusters. Most of the common genes and their assigned canonical pathways and molecular functions in each cluster were shared between axotomy and NMDA, indicating that their temporal expression profiles and functional roles are similar. Some of the common genes, including protein tyrosine phosphatases, formed specific molecular networks. Studies using chemical activators/inhibitors and knockout mice have demonstrated that protein tyrosine phosphatase 1/2 and interleukin-1 beta are detrimental to cell survival, whereas endothelin 2, the proteasome and galanin are neuroprotective. Thus, our integrated time-resolved expression profiling of common genes with bioinformatics and functional validation can help us to better understand the precise molecular mechanisms of RGC survival and death.